Renaissance Group’s Collegium Pharmaceutical COLL Stock Holding History

Renaissance Group’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-47,140	Closed	-$931K	–	273
2021 Q3	$931K	Sell	47,140 -622	-1%	-$13.4K	0.04%	175
2021 Q2	$1.13M	Buy	47,762 +10,315	+28%	+$238K	0.05%	153
2021 Q1	$887K	Buy	37,447 +221	+0.6%	+$5.25K	0.04%	179
2020 Q4	$746K	Buy	37,226 +940	+3%	+$18.4K	0.03%	176
2020 Q3	$755K	Sell	36,286 -235	-0.6%	-$4.24K	0.03%	159
2020 Q2	$639K	Buy	36,521 +299	+0.8%	+$5.85K	0.03%	172
2020 Q1	$592K	Buy	36,222 +1,037	+3%	+$21.4K	0.03%	170
2019 Q4	$724K	Buy	+35,185	New	+$586K	0.03%	195

Other funds holding COLL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Renaissance Group's COLL Position: Q4 2021 in Review

Renaissance Group sold out of Collegium Pharmaceutical (COLL) in Q4 2021, closing a stake of 47,140 shares — an estimated $931K sold.

Renaissance Group first reported a position in COLL in Q4 2019 and held it in 8 quarters. The position peaked at $1.13M in Q2 2021. 159 funds tracked by Wall St. Rank hold COLL as of Q4 2021.

Renaissance Group reported no remaining Collegium Pharmaceutical position as of Q4 2021 after selling out during the quarter.
Renaissance Group sold 47,140 Collegium Pharmaceutical shares in Q4 2021, an estimated $931K.
Renaissance Group first reported a position in Collegium Pharmaceutical in Q4 2019 and held it in 8 quarters.
Renaissance Group's Collegium Pharmaceutical position peaked at $1.13M in Q2 2021.
159 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q4 2021.

Based on Renaissance Group's 13F filing for Q4 2021, filed 11 Feb 2022.